Photomedicine Market Report 2025

The photomedicine market size has grown strongly in recent years. It will grow from $4.53 billion in 2024 to $4.95 billion in 2025 at a compound annual growth rate (CAGR) of 9.4%. The growth during the historic period can be attributed to the rising prevalence of skin disorders, increasing demand for non-invasive aesthetic procedures, the growing elderly population with age-related conditions, the higher incidence of skin-related illnesses, and the expansion of medical tourism.

The photomedicine market size is expected to see strong growth in the next few years. It will grow to $7.01 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to the rising prevalence of skin diseases, increasing demand for minimally invasive procedures, growing interest in aesthetic treatments, wider adoption of laser and light-based devices, and expanding research into new therapeutic applications. Key trends expected during this period include advancements in laser technology, the integration of phototherapy in oncology, technological progress in light-emitting diode (LED)-based treatments, innovations in photodynamic therapy, and the development of artificial intelligence-assisted diagnostics.

The rising number of cosmetic surgeries is expected to drive the growth of the photomedicine market in the coming years. Cosmetic surgeries are procedures carried out to alter or enhance a person’s appearance for aesthetic purposes. This increase is largely influenced by social media and the growing desire for improved self-image, as exposure to beauty standards and trends fuels demand for aesthetic enhancements. Photomedicine plays a key role in cosmetic procedures by offering precise, non-invasive treatments that improve skin tone, reduce blemishes, and enhance overall facial and body aesthetics with minimal recovery time. For example, in March 2023, the British Association of Aesthetic Plastic Surgeons, a UK-based surgical organization, reported 31,057 cosmetic surgeries in the UK in 2022, representing a 102% rise compared with the previous year. Therefore, the growth in cosmetic surgeries is fueling the expansion of the photomedicine market.

Companies in the photomedicine market are also advancing innovations such as light-emitting diode (LED) technology to expand treatment options and improve effectiveness. LED devices are non-invasive tools that deliver targeted wavelengths of light to activate cellular processes, supporting tissue healing and recovery while being applied in areas such as pain relief, skin rejuvenation, and therapeutic care. For instance, in April 2024, Bestqool, a US-based provider of red light therapy solutions, introduced a red-light therapy device specifically designed to relieve eczema symptoms. This device uses advanced light wavelengths to reduce inflammation, itching, and swelling, encouraging skin healing without side effects. Offering a drug-free alternative, the therapy has shown promising clinical results in managing eczema.

In July 2023, Alma, an Israel-based provider of energy-based medical and aesthetic solutions, acquired PhotonMed International Limited for $40 million. This acquisition allows Alma to strengthen its presence in the medical and aesthetic device industry while expanding its portfolio with advanced, user-focused technologies for healthcare and beauty treatments. PhotonMed International Limited, based in Hong Kong, specializes in photonics technologies for medical device applications.

Major players in the photomedicine market are BIOLASE Inc., Edmund Optics Inc., Lumenis Ltd., Candela Medical Inc., Fotona d.o.o., IRIDEX Corporation, PhotoCure ASA, Clinuvel Pharmaceuticals Limited, B&W Tek Inc., Erchonia Lasers Limited, Biolitec biomedical technology GmbH, RPMC Lasers Inc., Lynton Lasers Limited, Photonics Industries International Inc., Aspen Laser Systems LLC, Carl Zeiss AG, LightStim LLC, PhotoMedex Inc., Quanta Systems Ltd., THOR Photomedicine Limited.

North America was the largest region in the photomedicine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in photomedicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the photomedicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

Photomedicine is a field of medicine that employs light-based technologies to diagnose and treat a variety of conditions. By using specific wavelengths of light, it can stimulate biological responses, destroy harmful cells, and promote tissue regeneration. Photomedicine techniques are typically non-invasive or minimally invasive, making treatments more precise, safer, and faster to recover from.

The main types of photomedicine include light-emitting diodes (LEDs), lasers, full-spectrum light, polychromatic polarized light, dichroic lamps, and fluorescent lamps. Light-emitting diodes (LEDs) are gentle, non-invasive light sources that emit targeted wavelengths to activate cellular processes and facilitate therapeutic healing. Photomedicine is applied in a wide range of areas, including oncology, dermatology, pain management, dental procedures, aesthetics, and ophthalmology, among others. It is used by various end users, such as hospitals and clinics, dermatology and ophthalmology centers, home-based therapy setups, and research and academic institutions.

The photomedicine market research report is one of a series of new reports that provides photomedicine market statistics, including photomedicine industry global market size, regional shares, competitors with a photomedicine market share, detailed photomedicine market segments, market trends and opportunities, and any further data you may need to thrive in the photomedicine industry. This photomedicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The photomedicine market consists of revenues earned by entities providing services such as light-based diagnostics, skin rejuvenation, low-level light therapy, and photodynamic therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The photomedicine market also includes sales of intense pulsed light systems, optical sensors, and phototherapy systems. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.